Evidence map›Paper›PMID 33903218›Full record

ArticleLife science alliance2021

Fast but not furious: a streamlined selection method for genome-edited cells.

Haribaskar Ramachandran, Soraia Martins, Zacharias Kontarakis, Jean Krutmann, Andrea Rossi

Abstract read
In one paragraph

Article in Life science alliance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Reporter Alleles in hiPSCs: Visual Cues on Development and Disease.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. mtDNA analysis using Mitopore.Molecular therapy. Methods & clinical development · 2024
    Article
  7. Review
  8. Article
  9. Enrichment strategies to enhance genome editing.Journal of biomedical science · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haribaskar RamachandranIUF-Leibniz Research Institute for Environmental Medicine, Core Unit Model Development, Düsseldorf, Germany.
Soraia MartinsIUF-Leibniz Research Institute for Environmental Medicine, Core Unit Model Development, Düsseldorf, Germany.ORCID 0000-0002-7894-6539
Zacharias KontarakisGenome Engineering and Measurement Laboratory, Eidgenössische Technische Hochschule (ETH) Zurich, Zurich, Switzerland.ORCID 0000-0001-8825-8513
Jean KrutmannIUF-Leibniz Research Institute for Environmental Medicine, Core Unit Model Development, Düsseldorf, Germany.ORCID 0000-0001-8433-1517
Andrea RossiIUF-Leibniz Research Institute for Environmental Medicine, Core Unit Model Development, Düsseldorf, Germany Andrea.Rossi@IUF-Duesseldorf.de.ORCID 0000-0001-5863-6448

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, transcription activator-like effector nucleases and CRISPR-based genome engineering have revolutionized our approach to biology. Because of their high efficiency and ease of use, the development of custom knock-out and knock-in animal or cell models is now within reach for almost every laboratory. Nonetheless, the generation of genetically modified cells often requires a selection step, usually achieved by antibiotics or fluorescent markers. The choice of the selection marker is based on the available laboratory resources, such as cell types, and parameters such as time and cost should also be taken into consideration. Here, we present a new and fast strategy called magnetic-activated genome-edited cell sorting, to select genetically modified cells based on the ability to magnetically sort surface antigens (i.e., tCD19) present in Cas9-positive cells. By using magnetic-activated genome-edited cell sorting, we successfully generated and isolated genetically modified human-induced pluripotent stem cells, primary human fibroblasts, SH-SY5Y neuroblast-like cells, HaCaT and HEK 293T cells. Our strategy expands the genome editing toolbox by offering a fast, cheap, and an easy to use alternative to the available selection methods.

Indexed as

AnimalsBiomarkersCell LineCell SeparationClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsGene EditingGenomeHEK293 CellsHumansMagneticsTranscription Activator-Like Effector NucleasesBiomarkersTranscription Activator-Like Effector Nucleases

Identifiers

PMID33903218
PMCPMC8127327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.